Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EU.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.256EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.248EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.70EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.559EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.406EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.69EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ER.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.640EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
AY.43.6 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.9 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XUEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.3 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.16.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.372EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.425EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.144EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.288EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.249EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.378EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.97EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.439EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.408EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.256EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.7 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.460EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.262EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used